Carl Zeiss Meditec AG (AFX)
XETR
Closed
Aug 24, 2026
Day's Range
32.3052 wk Range
22.62Overview - AFX - Carl Zeiss Meditec AG
Key Statistics
Valuation
Enterprise Value
3.36B
P/E (Trailing)
‪23.70‬
P/E (Forward)
‪20.89‬
PEG Ratio
‪-0.17‬
Price / Sales (TTM)
‪1.30‬
Price / Book
‪1.35‬
EV / EBITDA
‪15.46‬
Profitability
Gross Margin
‪48.62%‬
Profit Margin
‪5.57%‬
Operating Margin
‪11.06%‬
Return on Assets
‪4.15%‬
Return on Equity
‪6.63%‬
Ownership
Shares Outstanding
87.53M
Float
34.18M
Held by Insiders
‪59.13%‬
Held by Institutions
‪17.81%‬
Price stats
Beta
‪1.34‬
50-Day Avg
‪28.94‬
200-Day Avg
‪30.46‬
Dividends
Payout Ratio
‪43.80%‬
Frequency
Annual
Analyst Consensus
15 analysts
Average price target
‪€ 27.24‬Market Cap - AFX - Carl Zeiss Meditec AG
Peers - AFX - Carl Zeiss Meditec AG
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on XETR.
- AFXXETRCarl Zeiss Meditec AG2.84BMarket Cap-31.58%52-week change23.71P/E (Trailing)‪5.57%‬Profit Margin
- IUI1XETRIntuitive Surgical, Inc.116.60BMarket Cap-24.67%52-week change42.38P/E (Trailing)‪28.44%‬Profit Margin
- ESLXETREssilorLuxottica75.32BMarket Cap-70.63%52-week change30.64P/E (Trailing)‪8.51%‬Profit Margin
- BOXXETRBecton, Dickinson and Company45.97BMarket Cap-1.42%52-week change34.10P/E (Trailing)‪4.19%‬Profit Margin
- 2U3XETRAlcon Inc.30.37BMarket Cap-8.36%52-week change56.11P/E (Trailing)‪5.92%‬Profit Margin
- 56S1XETRSartorius Stedim Biotech S.A.18.69BMarket Cap+7.36%52-week change64.07P/E (Trailing)‪9.73%‬Profit Margin
- SRT3XETRSartorius AG Preference Shares17.04BMarket Cap+20.94%52-week change86.97P/E (Trailing)‪5.47%‬Profit Margin
Profile Summary - AFX - Carl Zeiss Meditec AG
About
Carl Zeiss Meditec AG is a leading medical technology company specializing in ophthalmology and microsurgery solutions. Headquartered in Jena, Germany, and founded in 1846, it operates as a subsidiary of the ZEISS Group, delivering innovative products for diagnosing and treating eye diseases such as ametropia,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
